| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/06/2010 | US20100113586 Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms |
| 05/06/2010 | US20100113584 Novel use of (-)-epigallocatechin gallate |
| 05/06/2010 | US20100113578 Prevention of and countermeasures against mitochondrial disease |
| 05/06/2010 | US20100113576 Device and Method for Processing or Treating Surfaces By Means of A Dry Ice Granulate |
| 05/06/2010 | US20100113574 Polynucleotides for enhancing expression of a polynucleotide of interest |
| 05/06/2010 | US20100113564 Chemically synthesized nucleic acid molecule; nucleic acids with a pyrimidine modification; inflammatory, respiratory, pulmonary, autoimmune, cardiovascular, neurodegenerative, and/or proliferative and cancerous diseases, traits, or conditions |
| 05/06/2010 | US20100113559 Chitosan Based Polymer Conjugate and a Method for Producing the Same |
| 05/06/2010 | US20100113548 Antagonists of bitter taste receptors and uses thereof |
| 05/06/2010 | US20100113512 Method of treatment using novel antagonists or inverse agonists at opioid receptors |
| 05/06/2010 | US20100113501 Ophthalmic Composition Comprising Ascomycin |
| 05/06/2010 | US20100113468 Quinazoline derivatives as kinase inhibitors |
| 05/06/2010 | US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 |
| 05/06/2010 | US20100113403 Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism |
| 05/06/2010 | US20100113396 Method and Composition for Potentiating an Opiate Analgesic |
| 05/06/2010 | US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 05/06/2010 | US20100113386 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof |
| 05/06/2010 | US20100113353 Method and composition for inhibiting cardiovascular cell proliferation |
| 05/06/2010 | US20100113348 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption |
| 05/06/2010 | US20100112086 Electrolytically reduced water, hot water for bathing, and method for suppression of lumpy fat |
| 05/06/2010 | US20100112073 Water-Soluble Nanoparticles Containing Water-Insoluble Compounds |
| 05/06/2010 | US20100112072 Controllable Virus/Protein Assemblies and Methods of Making the Same |
| 05/06/2010 | US20100112069 Flowable Carrier Matrix |
| 05/06/2010 | US20100112068 Compositions and methods for biological remodeling with frozen particle compositions |
| 05/06/2010 | US20100112064 Transdermal therapeutic system comprising ion pair microreservoirs |
| 05/06/2010 | US20100112032 Bone/Polyurethane Composites and Methods Thereof |
| 05/06/2010 | US20100112015 Orally administered agent and an orally administered agent/supporting substrate complex |
| 05/06/2010 | US20100112003 Bifidobacterium in the treatment of inflammatory disease |
| 05/06/2010 | US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 05/06/2010 | US20100111968 Methods for Mediating Fibrotic Response |
| 05/06/2010 | US20100111924 Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site |
| 05/06/2010 | US20100111921 Use of IL-1 Antagonists to Treat Gout |
| 05/06/2010 | US20100111917 Cell-adhesive polyelectrolyte material for use as membrane and coating |
| 05/06/2010 | US20100111912 Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer |
| 05/06/2010 | US20100111911 Mitochondrial nucleic acid delivery systems |
| 05/06/2010 | US20100111888 Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions |
| 05/06/2010 | US20100111869 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 05/06/2010 | US20100111845 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111841 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111840 Stabilized therapeutic and imaging agents |
| 05/06/2010 | US20100111831 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | CA2741798A1 Anti-muc1 antibody |
| 05/06/2010 | CA2741783A1 Compounds having tafia inhibitory activity |
| 05/06/2010 | CA2741664A1 Method for selective control of helper t cell function |
| 05/06/2010 | CA2741658A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 05/06/2010 | CA2741646A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for disease accompanied by central nervous system disorders |
| 05/06/2010 | CA2740058A1 An antidiabetic agent |
| 05/05/2010 | EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 05/05/2010 | EP2182003A1 Peptide capable of binding to immunoglobulin |
| 05/05/2010 | EP2181992A1 Polycyclic compound |
| 05/05/2010 | EP2181987A1 Heterocyclic compound and use thereof |
| 05/05/2010 | EP2181985A1 Antiviral Agent |
| 05/05/2010 | EP2181984A1 AN OPTICALLY ACTIVE N- (alpha-MERCAPTOPROPIONY) GLYCINE |
| 05/05/2010 | EP1790655B1 Biologically active peptides |
| 05/05/2010 | EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 05/05/2010 | EP1411993B1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 05/05/2010 | EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 05/05/2010 | EP1248803B1 Nogo receptor-mediated blockade of axonal growth |
| 05/05/2010 | EP1227803B1 compounds for inhibiting iapp-associated amyloid deposits |
| 05/05/2010 | EP1167366B1 Amine derivatives |
| 05/05/2010 | EP1166788B1 Remedies for joint diseases |
| 05/05/2010 | EP1162976B1 16-phenoxy-lipoxin analogs for medical use |
| 05/05/2010 | EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/05/2010 | EP1089969B1 Stable no-delivering compounds |
| 05/05/2010 | CN1981837B Chinese-medicinal composition for adjusting human-body viscera function |
| 05/05/2010 | CN1954812B Use of Edaravone |
| 05/05/2010 | CN1947792B Method for preparing active protein composition type nano-selenium and its liquid phase storage tech. |
| 05/05/2010 | CN1921875B Beverage and medicine having bamboo extractive as main component |
| 05/05/2010 | CN1875769B Brain-nourishing health food and preparation method thereof |
| 05/05/2010 | CN1863779B Novel indazole derivative |
| 05/05/2010 | CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease |
| 05/05/2010 | CN1809353B Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 05/05/2010 | CN1744917B Sustained-release pharmaceutical composition for lung administration |
| 05/05/2010 | CN1679912B Extraction of liuwei Dihuang polysaccharide, products and use thereof |
| 05/05/2010 | CN1653454B Method of forming molecule function network |
| 05/05/2010 | CN1642574B Remedies for glomerular diseases |
| 05/05/2010 | CN1525859B Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 05/05/2010 | CN1511036B Combination comprising signal transduction inhibitor and epothilone derivative |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/05/2010 | CN1420924B Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof |
| 05/05/2010 | CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases |
| 05/05/2010 | CN101700347A Drug for curing strumitis and preparation method thereof |
| 05/05/2010 | CN101700229A Prostaglandin E1 long-circulation fat microsphere preparation for intravenous injection and preparation method thereof |
| 05/05/2010 | CN101056859B Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand |
| 05/05/2010 | CN101001629B Medicinal composition |
| 05/04/2010 | USRE41315 Modulators of dopamine neurotransmission |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709640 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 05/04/2010 | US7709535 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 05/04/2010 | US7709526 Use of cyclolignans and new cyclolignans |
| 05/04/2010 | US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration |
| 05/04/2010 | US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709479 Quinazoline derivatives and their use as pharmaceuticals |
| 05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 05/04/2010 | US7709455 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/04/2010 | US7709452 Pharmaceutical composition which improves in vivo gene transfer |